Clinical trials
Phase 3 Breast Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
225 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 8 |
| 2002 | 5 |
| 2003 | 13 |
| 2004 | 12 |
| 2005 | 6 |
| 2006 | 14 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 8 |
| 2014 | 9 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 9 |
| 2020 | 5 |
| 2021 | 17 |
| 2022 | 7 |
| 2023 | 11 |
| 2024 | 5 |
| 2025 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 134 |
| Active, not recruiting | 47 |
| Recruiting | 19 |
| Terminated | 15 |
| Unknown status | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 31 |
| AstraZeneca | 20 |
| Novartis Pharmaceuticals | 16 |
| NSABP Foundation Inc | 12 |
| Alliance for Clinical Trials in Oncology | 10 |
| NCIC Clinical Trials Group | 8 |
| Pfizer | 8 |
| Eli Lilly and Company | 6 |
| Merck Sharp & Dohme LLC | 5 |
| NRG Oncology | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 225 |
| Neoplasm Metastasis | 25 |
| Neoplasms | 12 |
| Breast Diseases | 6 |
| Breast Neoplasms, Male | 6 |
| Lung Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Brain Neoplasms | 5 |
| Neoplasms by Site | 5 |
| Carcinoma, Ductal, Breast | 4 |
Trials
Showing 1 to 25 of 225. Each trial links to its page on Pharma Observatory.
125 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.